Please login to the form below

Not currently logged in

Merck acquires pre-clinical biotech Calporta for up to $576m

Merck & Co HQExpands into early-stage neurodegeneration research field

Nucala works in rare inflammatory disease, says GSK

Nucala autoinjectorCompany is planning to file for approval in indication next year

UK biotech Evgen craters on failed stroke trial

Brain scanShares in the biotech more than halved following the news

Otsuka presses on with Alzheimer’s agitation drug

Otsuka Pharma logoSurprise announcement comes on the heels of phase 3 trial fail

Roche’s Spinraza, Zolgensma rival risdiplam hits the mark in SMA

Roche Basel SwitzerlandWill file for approval in US and other world markets before end of the year

Novartis makes case for NASH candidate tropifexor

Novartis dayRace to market intensifies as rivals strive to win first-in-class

Takeda’s dengue vaccine seems safe with no prior virus exposure

TakedaAppears unaffected by serious safety issue affecting Sanofi rival

Evotec and Vifor announce joint venture for kidney disease treatments

EvotecBoth companies will split the clinical and commercial costs equally

clusterAdopting a creative IP approach towards biotech clusters

Why big pharma paradigm needs to change

Featured jobs

Subscribe to our email news alerts


Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...
APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...